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COMMENTARY
MEDICINE AND LAW
ONLINE FIRST
Reforming the World Health Organization
Devi Sridhar, DPhil
Lawrence O. Gostin, JD
IN DECEMBER 2010, JACK CHOW,
1 THE FORMER WORLD
Health Organization (WHO) assistant director-
general, asked, “Is the WHO becoming irrelevant?” A
month later, theWHO’s executive board considered the
agency’s futurewithin global health governance. After a year-
long consultation with member states on its financing, Di-
rector-General Margaret Chan called the WHO overex-
tended andunable to respondwith speed and agility to today’s
global health challenges.2
The crisis in leadership is not surprising to those famil-
iar with theWHO. As its first specialized agency, the United
Nations (UN) endowed the WHO with extensive norma-
tive powers to act as the directing and coordinating author-
ity on international health. Yet modern global health ini-
tiatives (eg, the Global Fund to Fight AIDS, Tuberculosis
andMalaria and the GAVI Alliance [formerly the Global Al-
liance for Vaccines and Immunisation]), bilateral pro-
grams (eg, US President’s Emergency Plan for AIDS Relief
[PEPFAR]), and well-funded philanthropies (eg, the Bill &
Melinda Gates Foundation) often overshadow the agency.
The WHO can be subject to political pressure, and its rela-
tionship with industry and civil society is uncertain.3
Given the importance of global health cooperation, few
would dispute that a stronger, more effective WHO would
benefit all. TheWHO’s internal reform agendamust be bold
to ensure its future. In this Commentary, we offer 5 pro-
posals for reestablishing the agency’s leadership.
Give Real Voice to Multiple Stakeholders
As a UN agency, the WHO consists solely of member states,
which govern through the World Health Assembly (WHA)
and the executive board. Yet nonstate actors have becomema-
jor stakeholders in global health, often shifting their re-
sources to new initiatives with governance structures reflect-
ing their power. Known in international relations as forum
shopping, stakeholders choose specific institutions to pur-
sue their interests. In contrast to the WHO, representatives
from civil society, the private sector, and foundations sit on
the boards of the Global Fund and the GAVI Alliance. Even
UN agencies such as the Joint UnitedNations Programme on
HIV/AIDS engage civil society through advisory committees.
TheWHOwouldbemoreeffectivebygivingvoice andrep-
resentationtokeystakeholders, includingphilanthropies,busi-
nesses,public/privatepartnerships,andcivil society.Whileac-
tively engagingwith the private sector, theWHOshould also
set standards for and ensure compliance of key private part-
ners such as the food, pharmaceutical, andbiotechnology in-
dustries.At the same time, conflict-of-interest rules for expert
committees and contractors require clarity and enforcement.
The director-general is taking a major step in proposing
a global health forum, which would include regular mul-
tistakeholdermeetings under the guidance of theWHA.2 The
global health forummust afford stakeholders real voice and
representation, effectively shaping theWHO’s decisions. The
WHA should also pass a resolution lowering the bar to of-
ficial nongovernmental organization status.Meaningful stake-
holder engagement would instill confidence and spark in-
vestment in the agency.
Improve Transparency, Performance, and
Accountability
Good governance also requires clear objectives, transpar-
ent decision making, information dissemination, monitor-
ing progress, and accountability. Stakeholders demand clar-
ity on how their resources will achieve improved health
outcomes as they shift toward results-based financing and
performance-basedmeasures. Yet a recent evaluation ofmul-
tilateral organizations graded theWHOasweak on key para-
meters such as cost-consciousness, financial management,
public disclosure, and fulfilling development objectives.4 To
improve its standing, theWHOmustmake it easier for stake-
holders to monitor achievements and demonstrate that ac-
tivities effectively translate into better health outcomes.
Closer Oversight of Regions
The WHO’s decentralized, regional structure poses a sig-
nificant challenge in demonstrating results and delivering
on priorities. The 6 WHO regional offices are uniquely in-
dependent within the UN system, with full power over re-
gional personnel, including appointment of country repre-
sentatives. Regional committeesmeet annually to formulate
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policies, review the regional program budget, and monitor
theWHO’s collaborative activities for health. TheWHA and
the executive board formally approve decisions, but in prac-
tice do not provide tight policy and budgetary control.
The headquarters of theWHO should exercisemore over-
sight and control over regional personnel and decisionmak-
ing. Minimally, the agency should fully disclose the funds
heldwithin each regional office and how regionsmeet health
objectives,withmonitoring and benchmarks of success. Even
if decentralized decisionmaking remains the norm, theWHO
should apply the same yardstick across regions to assess ef-
ficiency and effectiveness.
Exert Legal Authority as a Rule-Making Body
TheWHO’s constitution grants the agency extraordinary rule-
making powers, but the agency has promulgated only 2ma-
jor treaties in more than 60 years: the International Health
Regulations and the Framework Convention on Tobacco
Control. The WHO could take a more active role in regu-
lating for the world’s health on key issues, including coun-
terfeit medicines, alcoholic beverages, food safety, and nu-
trition. It could be far more engaged and influential in
international regimes with powerful health impacts such as
trade, intellectual property, arms control, and climate change.
The agency could exert normative power through innova-
tive treaties (eg, a FrameworkConvention onGlobal Health)
or through soft power (eg, codes of practice) with strong in-
centives for compliance.5 TheWHOmust offer leadership for
urgent challenges facing the global health system such as the
needtosetclearpriorities, facilitatecoherenceamongcurrently
fragmentedactors,andensurefairburdensharingamongstates.
Ensure Predictable, Sustainable Financing
The WHO is financed through 2 main streams. First, mem-
ber states pledge a specified proportion of total assessed con-
tributions calculated according to each country’s wealth and
population.TheWHAthenunanimously approves a core bud-
get. The second stream is through voluntary contributions of-
ten earmarked for specific diseases, sectors, or countries. The
development assistance committeeof theOrganisation forEco-
nomic Co-operation and Development calls extrabudgetary
funding “multi-bi” aid (ie, donors routing noncore funding
allocated for specific purposes throughmultilateral agencies).6
TheWHO’s biennial budget more than doubled fromUS
$1.6 billion in 1998-1999 to US $4.2 billion in 2008-2009,
but the agency has a dire budget deficit of US $300 million
this year. More importantly, its extrabudgetary budget in-
creased from 48.8% to 77.3% during that period.7 It is not
sustainable to have voluntary funding represent nearly 80%
of the agency’s budget.
Moreover, extrabudgetary funding skews global health pri-
orities. Assessed contributions aremore alignedwith the ac-
tual global burden of disease than extrabudgetary funding.
For example, in 2008-2009, theWHO’s extrabudgetary fund-
ingwas primarily for infectious diseases (60%) and had neg-
ligible allocations for noncommunicable diseases (3.9%) and
injuries (3.4%).7 Yet noncommunicable diseases account for
62% of all deaths worldwide,8 and injuries account for 17%
of the global burden of disease.9
The director-general’s report proposes broadening the base
for flexible, unearmarked funding by attracting new donors
such as foundations, emerging economies, and theprivate sec-
tor.2 Althoughworthwhile, these stakeholders are unlikely to
behave differently than traditional donors, and probably will
prefer to control their funds through earmarks. The ideal so-
lutionwould be for theWHA to set highermember state con-
tributions. Member states must become genuine sharehold-
ers inWHO’s future, act collectively, and refrain fromexerting
narrow political interests. Failing decisive WHA action, the
WHO could consider charging overheads of 20% to 30% for
voluntary contributions to supplement its core budget. Al-
though overheads are a familiarmodel in academia, theWHO
would have to guard against the risk that chargesmight drive
donors toward other multilateral organizations.
Global Health Leadership
If theWHO is to hold its rightful place as the leader in global
health governance, the organization must undergo funda-
mental reform. There is no substitute for the WHO, with its
progressive constitution and global legitimacy. It is not likely
that the same powerswould be granted to an international or-
ganization if it were created today. Consequently, while re-
maining true to its normative and bold vision of health for all,
theWHOmust adapt to a new political climate, demonstrate
global leadership, and deliver results.
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